FDA
approval
· 2025-03-03
FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Original Application (Lifestar Pharma LLC)
Summary
The FDA approved a generic fixed-dose combination of telmisartan and hydrochlorothiazide (ANDA 218406) for hypertension, manufactured by Lifestar Pharma LLC.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TELMISARTAN AND HYDROCHLOROTHIAZIDE (TELMISARTAN AND HYDROCHLOROTHIAZIDE)